Celldex Therapeutics buy Canaccord Genuity Group Inc.
Start price
22.07.26
/
50%
€30.47
Target price
22.07.27
€52.60
Performance (%)
0.00%
Price
24.07.26
€30.68
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr is currently unchanged from the start price. This prediction currently runs until 22.07.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Celldex Therapeutics | 0.00% |
| iShares Core DAX® | 0,85 % |
| iShares Nasdaq 100 | -0,99 % |
| iShares Nikkei 225® | -1,78 % |
| iShares S&P 500 | 0,06 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target lowered by Canaccord Genuity Group Inc. from $62.00 to $60.00. They now have a "buy" rating on the stock.
Ratings data for CLDX provided by MarketBeat